|Generic Name||Brand Name| Nucleoside reverse transcriptase
inhibitors (NRTIs) are medicines that slow the ability of the
hepatitis B virus (HBV) to multiply in the body. They are taken
as pills once a day for at least a year, and usually much
longer. Entecavir is also available as a liquid that you
swallow. Adefovir, entecavir, telbivudine, and tenofovir are
approved by the U.S. Food and Drug Administration (FDA) for use
in adults. Lamivudine is approved for use by adults and by
children ages 2 to 17. NRTIs are used to treat long-term
(chronic) HBV infection in adults and children who are at risk
for liver disease. The American Association for the Study of
Liver Disease has made recommendations on who should receive
treatment for chronic hepatitis B based on the presence of
hepatitis B antigens in your blood, the level of hepatitis B
virus DNA (HBV DNA) in your blood, and the levels of your liver
enzymes.1 Treatment for HBV infection is considered successful
if blood tests show that the virus is no longer mu